Analysis of the Safety of Minor Dermatologic Surgery Performed during Antiplatelet Therapy

DOI Web Site 17 References

Bibliographic Information

Other Title
  • 抗血小板薬内服下の皮膚科小手術の安全性に関する検討
  • コウケッショウバンヤク ナイフク カ ノ ヒフカ ショウシュジュツ ノ アンゼンセイ ニ カンスル ケントウ

Search this article

Abstract

The use of blood thinners such as aspirin has become a common therapy practice for various indications, and has especially increased among elderly patients. When these patients need to undergo cutaneous surgery, the dermatologic surgeon faces the dilemma of whether to stop the antiplatelet therapy and increase the possibility of various thrombotic events or to continue the treatment with blood thinners and confront the possibility of intra- and postoperative bleeding. To evaluate the risk of intra- and postoperative bleeding associated with the continuation of antiplatelet therapy, we performed cutaneous surgery in 22 patients who were taking antiplatelet medications. Only one patient (1/22, 4.8%) had a hematoma after the surgery. With regard to thrombotic complications, none of the patients had a thrombotic event such as myocardiac infarction or ischemic attack during or after the surgery. On the basis of our study, the frequency of significant postoperative bleeding after dermatologic surgery is uncommon; thus, we conclude that cutaneous surgery with antiplatelet drugs is relatively safe.

Journal

References(17)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top